« PreviousNext »International Journal of Radiation Oncology * Biology * Physics
Volume 73, Issue 2 , Pages 327-333, 1 February 2009
Volume 73, Issue 2 , Pages 327-333, 1 February 2009
Final Report of Multicenter Canadian Phase III Randomized Trial of 3 Versus 8 Months of Neoadjuvant Androgen Deprivation Therapy Before Conventional-Dose Radiotherapy for Clinically Localized Prostate Cancer
To access this article, please choose from the options below
Supported by AstraZeneca and Schering-Plough.
Conflict of interest: none.
PII: S0360-3016(08)00830-4
doi:10.1016/j.ijrobp.2008.04.075
© 2009 Elsevier Inc. All rights reserved.
« PreviousNext »International Journal of Radiation Oncology * Biology * Physics
Volume 73, Issue 2 , Pages 327-333, 1 February 2009
Volume 73, Issue 2 , Pages 327-333, 1 February 2009
